Table I.
Before | After 2 months | At withdrawal | ||
---|---|---|---|---|
Case1 | mLoSSI | 6 | 3 | 1 |
LosDi | 7 | 5 | 2 | |
Case2 | mLoSSI | 7 | 3 | 1 |
LosDi | 7 | 4 | 2 |
The LoSCAT scale was used to assess disease-related activity and damage, performed independently by 2 clinicians. All of the scores were considerably reduced after medication.
mLoSSI: modified LS Skin Severity Index, which measures disease activity; LosDi: Localized scleroderma Damage Index, which measures damage.